Ameresco Announces Landmark $240 Million Hydropower Project, Driving Energy Resiliency and Security in Alaska
The Sweetheart Lake Hydroelectric Facility is designed to generate an average of 116,000 megawatt-hours (MWh) annually, providing a 20% increase in baseload clean hydropower over Juneau's current electrical generation. The project scope also covers the installation of a battery energy storage system (BESS), over 40 miles of high-voltage transmission infrastructure, including eight miles of undersea cable that will cross Gilbert Bay, and an interconnection substation with the existing Snettisham Transmission line adding energy security to Alaska's capital city.
This utility will connect underserved, remote areas that have previously relied solely on diesel generation to a reliable, renewable energy source. These components will also enhance local grid reliability and resilience in an area with a history of extreme weather events, including a 2008 avalanche that resulted in power outages that lasted as long as two months. The project is anticipated to increase overall energy transmission in the state by 3%.
'This project is the catalyst for Juneau's sustained growth and prosperity, and we've used over 40 years of hydrological data to design hydropower operational parameters so that we can reliably produce energy in even the driest of years,' said Duff Mitchell, Managing Director, Juneau Hydropower. 'By harnessing the power of Alaska's waters, we're investing in a future where unprecedented events can be weathered with confidence. We've worked in harmony with local environmental scientists and stakeholders to create the reliable, resilient power needed by our community.'
Sweetheart Lake is located within the territorial limits of the City and Borough of Juneau, Alaska on the east shore of Gilbert Bay. Sweetheart Lake drains into Gilbert Bay (an arm of Port Snettisham) via Sweetheart Creek. The hydroelectric dam is expected to offset 82,012 metric tons of CO2 emissions annually. It will deliver reliable, renewable baseload electricity through a process that does not burn fossil fuels, create pollution, or harm wildlife; and enhances local ecology by utilizing the Sweetheart Lake habitat as a fishery. A true economic and environmental win for Juneau, Alaska, and our Nation.
One of the planned customers is Coeur Alaska, Inc.'s Kensington Mine, located 45 miles north-northwest of Juneau in the Tongass National Forest. The mine is currently powered by onsite diesel generators but is expected to transition to primarily renewable base-load energy to power operations once the Sweetheart Lake Hydroelectric Facility is operational.
'This multi-faceted project is a major milestone for both Alaska, Juneau Power and Ameresco,' said Nicole Bulgarino, President of Federal Solutions and Utility Infrastructure at Ameresco. 'We're proud to be working on this critical hydropower project and major electrical infrastructure that has factored in both community needs and responsible development, in addition to supporting energy reliability and long-term economic growth in line with the vision outlined in the Alaska Executive Order: Unleashing Alaska's Extraordinary Resource Potential.'
In addition to development and construction, the project includes a long-term Operations and Maintenance (O&M) contract, ensuring sustained performance.
To learn more about the hydropower solutions offered by Ameresco, visit https://www.ameresco.com/hydropower/.
About Ameresco, Inc.
Founded in 2000, Ameresco, Inc. (NYSE:AMRC) is a leading energy solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the global energy transition. Our comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. As a trusted full-service partner, Ameresco shows the way by reducing energy use and delivering diversified generation solutions to Federal, state and local governments, utilities, educational and healthcare institutions, housing authorities, and commercial and industrial customers. Headquartered in Framingham, MA, Ameresco has more than 1,500 employees providing local expertise in North America and Europe. For more information, visit www.ameresco.com.
The announcement of a customer's entry into a project contract is not necessarily indicative of the timing or amount of revenue from such contract, of Ameresco's overall revenue for any particular period or of trends in Ameresco's overall total project backlog. This project was included in Ameresco's previously reported contracted backlog as of March 31, 2025.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
Key Points Hims & Hers Health is unlocking new sources of growth potential, and its balance sheet is flourishing. Doximity is a prime platform for advertisers, and the profits are pouring in. 10 stocks we like better than Hims & Hers Health › It's been a wild first half of the year for stocks in 2025, but finding the right companies for your portfolio is a very personal process. You need to consider the type of stocks you want to buy, the industries and sectors you gravitate toward, the amount of capital you have to invest, and your own personal risk tolerance. If you have cash to invest in the stock market right now, and you're looking for growth stocks that could make smart additions to the basket of businesses you own, there are names to be found across a range of industries, including healthcare. Here are two healthcare stocks that have at least doubled over the past 12 months but still look poised to deliver favorable returns for shareholders in the next three to five years. 1. Hims & Hers Health Hims & Hers Health (NYSE: HIMS) has witnessed a stock run-up of more than 200% over the trailing-12-month period. In contrast, the S&P 500 is up only about 18% in that same time frame. This boom in the company's share price has occurred for a few reasons. Investors were particularly excited about the company's ability to offer affordable, compounded GLP-1 drugs for weight loss amid shortages of branded versions, and that fueled significant revenue growth and share-price appreciation. However, Hims & Hers can no longer mass-produce compounded drugs like semaglutide because the U.S. Food and Drug Administration declared the shortage resolved. While the company may still offer personalized doses where clinically applicable, its primary weight loss offerings are shifting to oral medications and liraglutide. In fact, Novo Nordisk, the maker of Wegovy (semaglutide for weight) and Ozempic (semaglutide for diabetes), ended its partnership with Hims & Hers, citing concerns over the latter company's promotion and sales of compounded semaglutide. While the company's offerings may evolve in the coming months and years, it has other sources of growth to lean on besides the weight loss segment. Hims & Hers' areas of focus include sexual health, hair loss, dermatology, mental health, and primary care. The platform also provides access to both over-the-counter and prescription treatments via online consultations with licensed healthcare professionals, and most of its revenue still comes from recurring subscriptions paid by healthcare consumers. The recent acquisition of Zava, a European digital health platform, seems to have boosted investor confidence in the future of the business outside of its ambitions in the weight loss industry. The addition of Zava to Hims & Hers' ecosystem will expand its reach into the U.K., Ireland, France, and Germany. Hims & Hers also plans to launch its platform in Canada in 2026. Revenue grew by 110% year over year in the first quarter, and the company is building upon an improving track record of profitability. Hims & Hers also delivered free cash flow of about $50 million in Q1. This business has a lot of potential. 2. Doximity Doximity (NYSE: DOCS) has seen shares pop by a bit more than 100% since this time one year ago. Doximity is known as the largest digital platform for U.S. medical professionals. It serves as a professional and social network for healthcare professionals including doctors, nurse practitioners, and physician assistants, and offers a wide variety of tools for communication, news, and career management. Doximity provides a curated newsfeed with the latest medical news and research relevant to different specialties, and also offers tools for job searches, salary comparisons, and reputation management. The platform even provides telehealth solutions, enabling virtual patient visits and consultations. The platform is free for healthcare professionals to use. This free access includes Doximity Dialer, a feature that allows secure communication with patients using a customized calling tool. The platform also offers free digital fax lines and access to Doximity Scribe, an AI-powered note-taking tool for verified clinicians. So, how does Doximity make money? From advertising and selling information. Doximity's platform is a prime digital marketing and advertising tool for pharmaceutical manufacturers and healthcare systems (like hospitals). These entities pay Doximity to advertise and promote their products and services to targeted medical professionals. Health systems and medical recruiting firms also pay Doximity to access its database of medical professionals for recruitment and hiring purposes. In Doximity's fiscal 2025, which ended March 31, revenue increased 20% from the prior fiscal year to $570.4 million. The company reported net income of $223.2 million, up 51% year over year, with free cash flow spiking 50% to $266.7 million. This healthcare stock is really an advertising business at its core, and a profitable one at that. These factors could induce some investors to take another long look at this top stock and I think it has room to run. Do the experts think Hims & Hers Health is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Hims & Hers Health make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,019% vs. just 178% for the S&P — that is beating the market by 841.12%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Rachel Warren has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Doximity and Hims & Hers Health. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. 2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run was originally published by The Motley Fool 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Miami Herald
2 hours ago
- Miami Herald
Lamborghini's First Personalized Temerario Glows in Grey and Blue
Lamborghini's shift toward electrified supercars continues with the introduction of the Temerario, the Italian marque's all-new plug-in hybrid coupe. The model represents the brand's departure from the Huracán and its long-serving V10 engine, which has been replaced by a more potent and efficient twin-turbo V8 hybrid setup. With the Temerario, Lamborghini completes its transition to a fully electrified product line alongside the Revuelto and the Urus SE. The latest development comes in the form of the first Temerario Ad Personam – a fully customized one-off model created by Lamborghini's personalization division. Revealed in Porto Cervo, Sardinia, during a private gathering, the build draws inspiration from the Mediterranean backdrop and introduces a tailored visual expression of the new hybrid Lamborghini. Dubbed the Temerario Porto Cervo, this one-off example is defined by a finish called Grigio Serget – a grey base that reveals embedded blue flakes under direct light. Gloss black elements in Nero Noctis outline the lower body, front splitter, rear diffuser, and side scoops. A slim pinstripe in Blu Royal provides a color break across the body, also found on the rear wing. Blue brake calipers hide behind Velador gloss black wheels, and matte black quad tailpipes add contrast at the rear. Inside, the blue-grey theme continues. Grigio Octans leather and Corsa Tex upholstery form the base of the cabin, while Blu Nethuns stitching and leather inserts appear across seat panels and door trims. Embroidery includes Lamborghini logos and a Temerario script with Tricolore detail along the cabin's rear wall. A profile of the car is stitched into the doors, while matte carbon trim and a red-detailed carbon steering wheel reinforce the supercar's driver-oriented purpose. Two plaques mark this unit's uniqueness: one reads Ad Personam on the driver-side B-pillar, the other tagged "Porto Cervo 2025" – to be replaced by the owner's custom plate before delivery. The Temerario is powered by an all-new 4.0-liter twin-turbo V8 engine paired with three electric motors. The gasoline engine alone delivers 789 hp with a 10,000 rpm redline. With hybrid assistance, total output reaches 907 hp. Power is routed to all four wheels via an 8-speed dual-clutch automatic. Lamborghini claims 0–100 km/h in 2.7 seconds and a top speed of 213 mph. The Temerario Porto Cervo is a one-off commission, though Lamborghini's Ad Personam program allows buyers to create similarly bespoke configurations. The standard model's MSRP hovers around $300,000. Production takes place alongside the Revuelto on Lamborghini's new hybrid-capable line in Sant'Agata Bolognese. Copyright 2025 The Arena Group, Inc. All Rights Reserved.
Business Upturn
3 hours ago
- Business Upturn
KBR Investor News: If You Have Suffered Losses in KBR, Inc. (NYSE: KBR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of KBR, Inc. (NYSE: KBR) resulting from allegations that KBR may have issued materially misleading business information to the investing public. SO WHAT: If you purchased KBR securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. WHAT IS THIS ABOUT: On June, 20, 2025, before the market opened, KBR issued a press release entitled 'KBR Announcement on HomeSafe Alliance Global Household Goods Contract.' The press release stated that 'HomeSafe Alliance, a KBR (NYSE: KBR) Joint Venture, informed us on June 18, 2025, that U.S. Transportation Command (TRANSCOM) has terminated HomeSafe's role in the Global Household Goods Contract, a contract designed to improve the moving system for military service members and their families.' On this news, KBR's stock fell $3.85 per share, or 7.2%, to close at $48.93 per share on June 20, 2025. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ——————————- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected]
